Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Prostate Cancer

Free Subscription 02.10.2023 2 BMC Urol 1 Br J Cancer 4 Br J Radiol 2 Eur J Radiol 7 Eur Urol 2 Int J Radiat Oncol Biol Phys 2 J Nucl Med 1 Oncogene 1 PLoS One 1 Prog Urol 3 Prostate 1 Radiologia (Engl Ed) 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Urol

1. JIANG R, Wang X, Li Z, Cai H, et al
   Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
   BMC Urol. 2023;23:150.
   PubMed         Abstract available
   
   
2. FARIA EF, Machado RD, Gualberto RJC, Milani MAV, et al
   Patient's safety and satisfaction on same day discharge after robotic and laparoscopic radical prostatectomy versus discharge after 24 or 48 h: a longitudinal randomized prospective study.
   BMC Urol. 2023;23:149.
   PubMed         Abstract available
   
   

   
   Br J Cancer

3. HOU Y, Jiang KW, Wang LL, Zhi R, et al
   Biopsy-free AI-aided precision MRI assessment in prediction of prostate cancer biochemical recurrence.
   Br J Cancer. 2023 Sep 27. doi: 10.1038/s41416-023-02441.
   PubMed         Abstract available
   
   

   
   Br J Radiol

4. KENDRICK J, Francis R, Hassan GM, Rowshanfarzad P, et al
   Prospective inter- and intra-tracer repeatability analysis of radiomics features in [(68)Ga]Ga-PSMA-11 and [(18)F]F-PSMA-1007 PET scans in metastatic prostate cancer.
   Br J Radiol. 2023 Sep 26:20221178. doi: 10.1259/bjr.20221178.
   PubMed         Abstract available
   
   
5. CASTAGNOLI F, Doners R, Tunariu N, Messiou C, et al
   Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement.
   Br J Radiol. 2023 Sep 26:20230240. doi: 10.1259/bjr.20230240.
   PubMed         Abstract available
   
   
6. SOLIMAN M, Elfatairy K, Ellessy RMI, Velichko YS, et al
   The utility of [(18)F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate Resistant Prostate Cancer Patients (nmCRPCp): Diagnostic performance and Impact on Management.
   Br J Radiol. 2023 Sep 26:20230414. doi: 10.1259/bjr.20230414.
   PubMed         Abstract available
   
   
7. GREWAL H, Kedar R, Dhillon G, Sidhu G, et al
   SpaceOAR hydrogel complications in prostate cancer: Pictorial review.
   Br J Radiol. 2023 Sep 26:20230717. doi: 10.1259/bjr.20230717.
   PubMed         Abstract available
   
   

   
   Eur J Radiol

8. ZHANG KS, Mayer P, Glemser PA, Tavakoli AA, et al
   Are T2WI PI-RADS sub-scores of transition zone prostate lesions biased by DWI information? A multi-reader, single-center study.
   Eur J Radiol. 2023;167:111026.
   PubMed         Abstract available
   
   
9. SABBAH M, Gutierrez P, Puech P
   MA-QC: Free online software for prostate MR quality control and PI-QUAL assessment.
   Eur J Radiol. 2023;167:111027.
   PubMed         Abstract available
   
   

   
   Eur Urol

10. BEATRICI E, Labban M, Stone BV, Filipas DK, et al
    Uncovering the Changing Treatment Landscape for Low-risk Prostate Cancer in the USA from 2010 to 2020: Insights from the National Cancer Data Base.
    Eur Urol. 2023 Sep 25:S0302-2838(23)03088-9. doi: 10.1016/j.eururo.2023.
    PubMed         Abstract available
    
    
11. PONTES-SILVA A
    Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023
    Eur Urol. 2023 Sep 25:S0302-2838(23)03094-4. doi: 10.1016/j.eururo.2023.
    PubMed        
    
    
12. ILIE G, Rutledge RDH
    Reply to Andre Pontes-Silva's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Tr
    Eur Urol. 2023 Sep 22:S0302-2838(23)03091-9. doi: 10.1016/j.eururo.2023.
    PubMed        
    
    
13. MAY M, Wolff I, Brookman-May SD
    Re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Undergoing Curative Prostate Cancer Treatment: A Randomized Clinical Trial. Eur Urol 2023
    Eur Urol. 2023 Sep 22:S0302-2838(23)03095-6. doi: 10.1016/j.eururo.2023.
    PubMed        
    
    
14. KLOTZ L
    Re: MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy.
    Eur Urol. 2023 Sep 22:S0302-2838(23)03080-4. doi: 10.1016/j.eururo.2023.
    PubMed        
    
    
15. OPREA-LAGER DE, MacLennan S, Bjartell A, Briganti A, et al
    European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
    Eur Urol. 2023 Sep 22:S0302-2838(23)03092-0. doi: 10.1016/j.eururo.2023.
    PubMed         Abstract available
    
    
16. ILIE G, Rutledge RDH
    Reply to Matthias May, Ingmar Wolff, and Sabine D. Brookman-May's Letter to the Editor re: Gabriela Ilie, Ricardo Rendon, Ross Mason, et al. A Comprehensive 6-mo Prostate Cancer Patient Empowerment Program Decreases Psychological Distress Among Men Un
    Eur Urol. 2023 Sep 22:S0302-2838(23)03093-2. doi: 10.1016/j.eururo.2023.
    PubMed        
    
    

    
    Int J Radiat Oncol Biol Phys

17. PETERSEN PM, Cook AD, Sydes MR, Clarke N, et al
    Salvage Radiation Therapy After Radical Prostatectomy: Analysis of Toxicity by Dose-Fractionation in the RADICALS-RT Trial.
    Int J Radiat Oncol Biol Phys. 2023;117:624-629.
    PubMed         Abstract available
    
    
18. LIU G, Zhao L, Li X, Zhang S, et al
    A Novel Ultrahigh-Dose-Rate Proton Therapy Technology: Spot-Scanning Proton Arc Therapy + FLASH (SPLASH).
    Int J Radiat Oncol Biol Phys. 2023;117:730-737.
    PubMed         Abstract available
    
    

    
    J Nucl Med

19. RINSCHEID A, Gable A, Wienand G, Pfob C, et al
    An Intrapatient Dosimetry Comparison of (177)Lu-rhPSMA-10.1 and (177)Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer.
    J Nucl Med. 2023 Sep 28:jnumed.123.265970. doi: 10.2967/jnumed.123.265970.
    PubMed         Abstract available
    
    
20. SHAGERA QA, Karfis I, Kristanto P, Spyridon S, et al
    PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors.
    J Nucl Med. 2023 Sep 28:jnumed.123.265874. doi: 10.2967/jnumed.123.265874.
    PubMed         Abstract available
    
    

    
    Oncogene

21. ADVANI R, Luzzi S, Scott E, Dalgliesh C, et al
    Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer.
    Oncogene. 2023 Sep 26. doi: 10.1038/s41388-023-02838.
    PubMed         Abstract available
    
    

    
    PLoS One

22. OKUMURA S, Ohsato Y
    A novel rapid detection method for a single-nucleotide substitution mutation derived from canine urothelial and prostatic carcinoma cells present in small amounts in urine sediments.
    PLoS One. 2023;18:e0286229.
    PubMed         Abstract available
    
    

    
    Prog Urol

23. DEBARD C, Margue G, Klein C, Rompre-Brodeur A, et al
    [Oncological and functional results of focal treatment of localized prostate cancer with HIFU].
    Prog Urol. 2023 Sep 26:S1166-7087(23)00215-4. doi: 10.1016/j.purol.2023.
    PubMed         Abstract available
    
    

    
    Prostate

24. ZOU P, Chen Z, He Q, Zhuo Y, et al
    Polyphyllin I induces ferroptosis in castration-resistant prostate cancer cells through the ERK/DNMT1/ACSL4 axis.
    Prostate. 2023 Sep 26. doi: 10.1002/pros.24626.
    PubMed         Abstract available
    
    
25. RAJWA P, Heidenreich J, Drzezga A, Schmidt M, et al
    The diagnostic accuracy of (68) Ga-PSMA-PET/CT in primary staging of patients with high-risk nonmetastatic prostate cancer treated with radical prostatectomy: A single-center cohort analysis.
    Prostate. 2023 Sep 26. doi: 10.1002/pros.24627.
    PubMed         Abstract available
    
    
26. ARAFA MA, Farhat KH, Khan FK, Rabah DM, et al
    Development and internal validation of a nomogram predicting significant prostate cancer: Is it clinically applicable in low prevalent prostate cancer countries? A multicenter study.
    Prostate. 2023 Sep 27. doi: 10.1002/pros.24625.
    PubMed         Abstract available
    
    

    
    Radiologia (Engl Ed)

27. VILANOVA JC, Catala-Sventzetzky V, Hernandez-Mancera J
    MRI for detection, staging, and follow-up of prostate cancer: Synthesis of the PI-RADS v2.1, MET-RADS, PRECISE, and PI-RR guidelines.
    Radiologia (Engl Ed). 2023;65:431-446.
    PubMed         Abstract available
    
    

    
    Radiology

28. BISCHOFF LM, Peeters JM, Weinhold L, Krausewitz P, et al
    Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI.
    Radiology. 2023;308:e230427.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: